How might new approaches and technologies help us to sense health needs earlier, empower individuals and communities to take control of their health, and shape health systems and technologies that are smarter and more inclusive?
Join Imperial alumni for an evening panel event exploring how convergence science can contribute to more equitable health outcomes worldwide.
The panel discussion will be chaired by Professor Anthony Bull FREng, Convening Director of the Health and Technology theme within Imperial’s School of Convergence Science.
Our interdisciplinary alumni panel will reflect on emerging tools, approaches and ways of working that have the potential to support prevention, improve access, and respond to health challenges across diverse populations and settings.
In addition to the panel conversation, attendees will get to experience a round of quick-fire pitches by Imperial founders, highlighting how the university’s innovation ecosystem is moving from concept to society, to empower patients as well as professionals and shape more inclusive health systems and technologies.
The evening will conclude with a networking reception, offering you the chance to connect with fellow alumni, speakers, founders and members of the Imperial community over refreshments.
Key details
Date: Tuesday 24 February
Time: 18.30 – 20.45
Location: 12th Floor, Sir Michael Uren Hub, White City Campus
Cost: £10 for alumni and guests, £5 for students
Register: book your spot now via Eventbrite.
Event highlights:
- Expert alumni panel discussion chaired by Professor Anthony Bull
- Imperial startup showcase
- Networking reception with snacks and drinks
Panellists
Lucy (Soo Min) Jung (MSc Innovation Design Engineering 2019)
Founder of LYEONS and Charco Neurotech, and an inventor of neuromodulation medical devices dedicated to improving the quality of life for people with long-term conditions. She is passionate about developing patient-centred solutions that combine technology, empathy, and accessibility.- At LYEONS, she leads the development of next-generation neuromodulation technology focused on autonomic nervous system regulation to support people experiencing anxiety, stress, trauma, and sleep disturbances. The company’s patient-first approach builds on her previous experiences at Charco Neurotech, where she led the creation of a device that significantly improved mobility symptoms in people with Parkinson’s. They have successfully raised over £14 million through venture capital, angel investors, and grant funding. Recently, Lucy was winner of the Entrepreneur Alumni Award 2025.
Michael Barker (MBA 2001)
- Michael currently holds the post of National Strategy
Director for the NHS’s New Hospital Programme. He has a lifelong career in healthcare, and is a Consultant Physiotherapist by background. He has held many healthcare executive posts at board level, leading complex projects that have set a new future for, and successfully transformed, healthcare organisations. - During the COVID-19 pandemic, he returned to clinical leadership as the Head of Physiotherapy for NHS Nightingale Hospital, London. He then spent 18 months at the Department of Health and Social Care leading the role out of the LAMP (saliva) COVID-19 testing programme. Alongside his current role, he has also created and led an initiative called ‘Healthcare London’, a partnership of private providers in London who are unlocking access for international patients to advance their care in London.
Director for the NHS’s New Hospital Programme. He has a lifelong career in healthcare, and is a Consultant Physiotherapist by background. He has held many healthcare executive posts at board level, leading complex projects that have set a new future for, and successfully transformed, healthcare organisations. Claire Trant (PhD Materials 2020)
- Scientist an
d Founder of Untap Health, working to make early illness detection more proactive, practical, and accessible. Untap Health, builds near-source, non-invasive monitoring systems that provide early warning of viral and bacterial infectious risk before symptoms appear. The work at Untap Health spans both human and animal health, supporting care environments, workplaces, farms, livestock settings, and other shared environments to act earlier, reduce disruption, and protect people and animal welfare. - Claire is passionate about translating rigorous science into real-world tools, and about building health protection infrastructure that is calm, privacy-preserving, and trustworthy.
d Founder of Dr Chiara Bucciarelli-Ducci (PhD Cardiovascular Imaging 2012)
Consultant Cardiologist at Royal Brompton & Harefield Hospitals. Alongside her current clinical and teaching commitments, Chiara is CEO of international non-profit Society for Cardiovascular Magnetic Resonance (SCMR), the principal international, independent organisation committed to the further development of CMR through education, quality control, research, and training. - Chiara was winner of the Emerging Alumni Leader Award 2022. Discover her story here.
Consultant Cardiologist at Royal Brompton & Harefield Hospitals. Alongside her current clinical and teaching commitments, Chiara is CEO of international non-profit Imperial founders showcasing at this event
- Building trustworthy,
explainable AI agents for healthcare that can call and speak with millions of patients simultaneously – preparing them for surgery, checking in post-procedure, and enabling proactive care by identifying those who need support early. The company works with leading healthcare providers and medical device manufacturers across the UK, EU and US to reduce clinical and administrative burden through evidence-based, near-zero-hallucination AI. Founded by alumnus Uddhav Vaghela (MBBS Medicine 2020).
explainable AI agents for healthcare that can call and speak with millions of patients simultaneously – preparing them for surgery, checking in post-procedure, and enabling proactive care by identifying those who need support early. The company works with leading healthcare providers and medical device manufacturers across the UK, EU and US to reduce clinical and administrative burden through evidence-based, near-zero-hallucination AI. Founded by alumnus - An innovative MedTech startup that spun out from Imperial in December 2020, established to commercia
lise the multidisciplinary research led by founders Professor Pantelis Georgiou, Dr Jesus Rodriguez Manzano, and Dr Nicolas Moser. Its mission is to transform disease management and improve health outcomes by using ground-breaking sample preparation and detection technologies to develop diagnostic tests for priority infections to be used at the point of need. - It aims to enable better healthcare through fast, portable, accurate, connected, and multiplex diagnostic technology that facilitate the decentralisation of testing, improve infection management and reduce inappropriate antimicrobial use, a key driver of antimicrobial resistance (AMR). ProtonDx’s tests are suitable for across sectors including food, environmental, livestock and animal/human healthcare. Its flagship Lacewing platform marks a new frontier in point-of-care molecular diagnostics using Lab-on-Chip Technology.
- The team have also commercialised Dragonfly PoC diagnostic device, which been adapted and field-deployed for detection of malaria and skin tropic viruses.
- Their first customers included athletes from Team GB at the Beijing 2022 Winter Olympics and the 2022 Commonwealth Games, and has travelled from the Arctic to Zambia, demonstrating the portability and versatility of the technology. ProtonDx was recently crowned winner of the 2025 Tesco Agri T-Jam innovation challenge.
About the Chair
Professor Anthony Bull is Convening 
Director of the Health and Technology theme within Imperial’s School of Convergence Science, and Professor of Musculoskeletal Mechanics in the Department of Bioengineering.
His research is focused on the basic mechanics of joints (including the tissues of joints and the mechanics of joints within the whole musculoskeletal system) and the application of this knowledge and technologies developed to the diagnosis and treatment of pathologies and performance parameters. These are applied to sport biomechanics, injury biomechanics (focusing on blast), and the biomechanics of ageing including osteoarthritis.
He leads the Centre for Blast Injury Studies that exists to improve the mitigation of injury, improve and advance treatment, rehabilitation and recovery thus increasing lifelong health and quality of life after blast injury.
About Imperial’s School of Convergence Science
This event reflects the mission of Imperial’s School of Convergence Science: Health and Technology, which exists to drive meaningful collaboration between disciplines, methods and mindsets to tackle society’s most complex health challenges.
By fostering collaboration across boundaries, the School seeks to shift the focus from treating illness to sustaining lifelong health – with equity, agency, and convergence science at its core.
Read more about the School here.